A natto-red yeast complex capsule structure

Abstract

A natto-red yeast complex capsule structure comprising: a capsule body, the capsule body comprising a first capsule shell and a second capsule shell, the first capsule shell having a circular cross-section, one end having a first opening, the other end having a circularly curved first closure end, and at least one first identification unit being provided on the outer surface of the first capsule shell; the second capsule shell having a circular cross-section, a second opening at one end and a circularly curved second closure at the other end, and the first opening of the first capsule shell and the second opening of the second capsule being joined to form a receiving space between the first capsule shell and the second capsule shell;and a content to be contained in the intake chamber, the composition of which comprises lemon extract, red yeast powder, natto bacterial ferment, vitamin E, grape seed extract, sesame seed extract, magnesium stearate and silicon dioxide.

Description

Technical area

[0001] The present utility model relates to a capsule structure, in particular a natto red yeast complex capsule structure. Technology in the background

[0002] According to global epidemiological statistics, noncommunicable diseases (NCDs) are currently the most important factors affecting human health and socioeconomic development. The 2013 World Health Assembly adopted the "Draft Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020," which aims to reduce morbidity and mortality from noncommunicable diseases, focusing on diseases with high morbidity and mortality, such as cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes mellitus. According to estimates by the World Economic Forum and the World Health Organization, noncommunicable diseases will have a significant impact on economic expenditures in low- and middle-income countries between 2011 and 2025.

[0003] In Taiwan, heart disease is among the top ten causes of death, and the incidence of hypertension is increasing every year. Therefore, cardiovascular disease has become a serious threat to the nation's health and requires attention and preventive measures. The Food and Drug Administration (FDA) of the Ministry of Health and Welfare (MOHW) has approved many healthy foods for regulating blood lipids, indicating that blood lipid regulation has become an important health issue.

[0004] Studies have shown that lipid-related research continues to receive attention, and lipid regulation has become an important direction in the development of international natural or healthy foods. Agricultural products, food factors, or phytochemicals are considered important sources of lipid-regulating supplements. In summary, the prevention and control of NCDs, especially cardiovascular diseases, requires global cooperation and sustained research efforts to improve human health and socioeconomic development.

[0005] Therefore, the question of how to improve the health threat of cardiovascular diseases by consuming healthy foods to support blood lipid regulation is an important issue that needs to be addressed in the field of this technology. Content of the utility model

[0006] Considering the above-mentioned problem to be solved, the present inventor thought of the idea of ​​a utility model and introduced this utility model after many discussions and trials and after many corrections and improvements.

[0007] The present utility model is a natto red yeast complex capsule structure comprising: a capsule body, the capsule body comprising a first capsule shell and a second capsule shell, the first capsule shell being circular in cross-section, having a first opening at one end and a rounded first closure end at the other end.The first capsule shell has at least one first identification unit on the outer surface of the first capsule shell, the second capsule shell has a circular cross-section, one end has a second opening and the other end has a circularly curved second closure end, the first opening of the first capsule shell and the second opening of the second capsule are fitted together to form a receiving space between the first capsule shell and the second capsule shell; and a content to be contained in the receiving space, the composition of the content comprising lemon extract, red yeast powder, natto bacterial ferment, vitamin E, grape seed extract, sesame seed extract, magnesium stearate, and silicon dioxide.

[0008] The main purpose of the present utility model natto red yeast composite capsule structure is to provide at least one first identification unit on the outer surface of the first capsule shell, which can be easily identified by consumers. Furthermore, the content composition includes lemon extract, red yeast powder, natto bacterial ferment, vitamin E, grape seed extract, sesame seed extract, magnesium stearate, and silicon dioxide to achieve the health benefits of regulating blood lipids and preventing cardiovascular diseases. Description of the attached drawings Fig. 1 is a three-dimensional drawing of the utility model. Fig. Figure 2 is a three-dimensional decomposition diagram of the utility model. Fig. 3 is a cross-sectional view of the first capsule shell and the second capsule shell of the utility model. Fig. Figure 4 is a plan view of the utility model. Fig. 5 is a sectional view of Fig. 4 along the AA line. Fig. 6 is an enlarged A1 section of Fig. 5. Fig. Figure 7 is a plan view of another example of the utility model. Fig. 8 is a plan view of the first capsule shell and the second capsule shell of another example of the utility model.

[0009] Description of the affixed reference numerals: 10 Capsule body; 11 First capsule shell; 111 First opening; 112 First closed end; 113 First identification unit; 12 Second capsule shell; 121 Second opening; 122 Second closed end; 123 Second identification unit; 13 Receptacle; 20 Content; 21 Lemon extract; 22 Red yeast powder; 23 Natto ferment; 24 Vitamin E; 25 Grape seed extract; 26 Sesame extract; 27 Magnesium stearate; 28 Silicon dioxide; L1 First length; L2 Second length; D1 Inner diameter; D2 Outer diameter Detailed description

[0010] The following illustrations of the improved embodiments of the utility model are described as follows to enable persons familiar with the relevant technology of the utility model to implement the utility model in accordance with the statements of the present specification.

[0011] First, reference is made to the first to sixth figures which show this utility model natto-red yeast composite capsule structure comprising: a capsule body 10 and a content 20.

[0012] The capsule body 10 comprises a first capsule shell 11 and a second capsule shell 12.

[0013] The first capsule shell 11 is made of edible material and is translucent or opaque. The first capsule shell 11 has a circular cross-section, one end has a first opening 111, the other end has a rounded first closed end 112, and the first capsule shell 11 has at least one first identification unit 113 on the outer surface. The first capsule shell 11 has a first length L1, the first opening 111 has an inner diameter D1, and in this embodiment, the first capsule shell 11 is provided with a first identification unit 113 on the outer surface of the first capsule shell 11, which has the shape of a diagram.

[0014] The second capsule shell 12 is made of edible material and is translucent or opaque. The second capsule shell 12 has a circular cross-section, one end has a second opening 121 and the other end has a second closed end 122 in the shape of a circular arc. The outer surface of the second capsule shell 12 is provided with at least one second identification unit 123. The second capsule shell 12 has a second length L2, the second opening 121 has an outer diameter D2. The second length L2 of the second capsule shell 12 is approximately equal to the first length L1 of the first capsule shell 11, and the outer diameter D2 of the second opening 121 is approximately equal to the inner diameter D1 of the first opening 111. The first opening 111 of the first capsule shell 11 is attached to the second opening 121 of the second capsule shell 12, thereby connecting the first opening 121 of the second capsule shell 11 to the second opening 121 of the second capsule.The first opening 111 of the first capsule shell 11 and the second opening 121 of the second capsule shell 12 are joined together to form a receiving space 13 between the first capsule shell 11 and the second capsule shell 12. In this embodiment, the second capsule shell 12 is provided with a second identification unit 123 on the outer surface, and the second identification unit 123 has the same pattern as the first identification unit 113.

[0015] Content 20 is in powder form and contained in the intake chamber 13. Content 20 is a nutritious, healthy food that can regulate blood lipids without the side effects found in natural foods. It consists of lemon extract (21), red yeast powder (22), natto ferment (23), vitamin E (24), grape seed extract (25), sesame extract (26), magnesium stearate (27), and silicon dioxide (28), which can be easily transported and consumed by consumers to solve the health crisis of modern people. The recommended daily intake for adults is 2 capsules of Natto Red Yeast Complex, with a total weight of 1,000 mg of Content 20 (500 mg per capsule of Content 20), which can help regulate blood lipids and prevent cardiovascular diseases.

[0016] In the Fig. 7 and Fig.Figure 8 shows another embodiment of the capsule structure of the natto red yeast compound utility model, which differs from the above embodiment in that the first capsule shell 11 is provided with four first identification units 113 in a stacked form on the outer surface. The first identification unit 113 is colored, and each adjacent first identification unit 113 has a different color, and the second capsule shell 12 is provided with three second identification units 123 in a stacked form on the outer surface of the second capsule shell 12, which are colored, and each adjacent second identification unit 123 has a different color.

[0017] The following advantages can be achieved by the structure of the specific embodiment described above: The utility model natto red yeast complex capsule structure has at least one first identification unit 113 on the outer surface of the first capsule shell 11, which is convenient for consumers to easily identify the capsule and avoid confusion. The ingredients contained in the capsule include lemon extract 21, red yeast powder 22, natto ferment 23, vitamin E 24, grape seed extract 25, sesame extract 26, magnesium stearate 27, and silicon dioxide 28. The synergistic effect of these ingredients contributes to lowering serum triglycerides, total cholesterol, and LDL cholesterol, thereby effectively regulating blood lipids, preventing cardiovascular disease, and achieving health benefits. QUOTES CONTAINED IN THE DESCRIPTION

[0000] This list of documents submitted by the applicant was generated automatically and is included solely for the convenience of the reader. This list is not part of the German patent or utility model application. The DPMA assumes no liability for any errors or omissions. Cited non-patent literature

[0000] Draft Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020

[0002]

Claims

[1] A natto red yeast complex capsule structure comprising: a capsule body, the capsule body comprising a first capsule shell and a second capsule shell, the first capsule shell having a circular cross-section, one end having a first opening, the other end having a circularly curved first closure end, and at least one first identification unit being provided on the outer surface of the first capsule shell; the second capsule shell having a circular cross-section, a second opening at one end, and a circularly curved second closure at the other end, and the first opening of the first capsule shell and the second opening of the second capsule are fitted together to form a receiving space between the first capsule shell and the second capsule shell;and a content to be contained in the receiving space, the composition of the content comprising lemon extract, red yeast powder, natto bacterial ferment, vitamin E, grape seed extract, sesame seed extract, magnesium stearate, and silicon dioxide.; [2] A natto red yeast complex capsule structure according to claim 1, wherein the first identification unit is graphic or colored. [3] A natto red yeast complex capsule structure according to claim 1, wherein the second capsule shell is provided with at least one second identification unit on the outer surface. [4] A natto red yeast complex capsule structure according to claim 3, wherein the second identification unit is graphic or colored. [5] A natto red yeast complex capsule structure according to claim 1, wherein the first capsule shell is translucent or opaque. [6] A natto red yeast complex capsule structure according to claim 1, wherein the second capsule shell is translucent or opaque. [7] A natto red yeast complex capsule structure according to claim 1, wherein the first capsule shell and the second capsule shell are made of edible material. [8] A natto red yeast complex capsule structure according to claim 1, wherein the first capsule shell has a first length, the second capsule shell has a second length, and the second length is substantially equal to the first length. [9] A natto red yeast complex capsule structure according to claim 1, wherein the first opening has an inner diameter, the second opening has an outer diameter, and the second opening has an inner diameter substantially equal to the outer diameter of the first opening. [10] A natto red yeast complex capsule structure according to claim 1, wherein the contents are in powder form.

Images